Status:
UNKNOWN
Effect of Ropinirole Hydrochloride in Progressive Myoclonic Epilepsy of Unverricht-Lundborg Type
Lead Sponsor:
University of Turku
Conditions:
Unverricht-Lundborg Syndrome
Eligibility:
All Genders
18-70 years
Phase:
PHASE2
Brief Summary
The progressive myoclonus epilepsy of the Unverricht-Lundborg disease (ULD) type is an autosomal recessive disease characterized by progressive stimulus-sensitive and action-related myoclonic jerks. ...
Eligibility Criteria
Inclusion
- Unverricht-Lundborg Syndrome
Exclusion
- Pregnancy
- Intolerability to ropinirole hydrochloride
- Mental illness
Key Trial Info
Start Date :
August 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
16 Patients enrolled
Trial Details
Trial ID
NCT00639119
Start Date
August 1 2007
Last Update
March 19 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Turku university central hospital, Department of neurology
Turku, Finland, 20520